Today, treatments for obesity are based on two major approaches: GLP-1 drugs such as Ozempic and bariatric surgery. The former promise significant weight loss without operation, while the latter permanently alter digestive function. An American study has just compared their results under the actual conditions of daily medical follow-up. Bariatric surgery against Ozempic, 25.7% weight loss on one side, 5.3% on the other The New York University te…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
Today, treatments for obesity are based on two major approaches: GLP-1 drugs such as Ozempic and bariatric surgery. The former promise significant weight loss without operation, while the latter permanently alter digestive function. An American study has just compared their results under the actual conditions of daily medical follow-up. Bariatric surgery against Ozempic, 25.7% weight loss on one side, 5.3% on the other The New York University te…